Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
Department of Cardiology, The Third People's Hospital of Shenzhen, Shenzhen, China.
Clin Cardiol. 2020 Jul;43(7):796-802. doi: 10.1002/clc.23384. Epub 2020 Jun 20.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could cause virulent infection leading to Corona Virus Disease 2019 (COVID-19)-related pneumonia as well as multiple organ injuries.
COVID-19 infection may result in cardiovascular manifestations leading to worse clinical outcome.
Fifty four severe and critical patients with confirmed COVID-19 were enrolled. Risk factors predicting the severity of COVID-19 were analyzed.
Of the 54 patients (56.1 ± 13.5 years old, 66.7% male) with COVID-19, 39 were diagnosed as severe and 15 as critical cases. The occurrence of diabetes, the level of D-dimer, inflammatory and cardiac markers in critical cases were significantly higher. Troponin I (TnI) elevation occurred in 42.6% of all the severe and critical patients. Three patients experienced hypotension at admission and were all diagnosed as critical cases consequently. Hypotension was found in one severe case and seven critical cases during hospitalization. Sinus tachycardia is the most common type of arrythmia and was observed in 23 severe patients and all the critical patients. Atrioventricular block and ventricular tachycardia were observed in critical patients at end stage while bradycardia and atrial fibrillation were less common. Mild pericardial effusion was observed in one severe case and five critical cases. Three critical cases suffered new onset of heart failure. Hypotension during treatment, severe myocardial injury and pericardial effusion were independent risk factors predicting the critical status of COVID-19 infection.
This study has systemically observed the impact of COVID-19 on cardiovascular system, including myocardial injury, blood pressure, arrythmia and cardiac function in severe and critical cases. Monitoring of vital signs and cardiac function of COVID-19 patients and applying potential interventions especially for those with hypotension during treatment, severe myocardial injury or pericardial effusion, is of vital importance.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)可引起烈性感染,导致 2019 年冠状病毒病(COVID-19)相关肺炎以及多器官损伤。
COVID-19 感染可能导致心血管表现,从而导致更差的临床结局。
纳入 54 例确诊 COVID-19 的重症和危重症患者。分析预测 COVID-19 严重程度的危险因素。
54 例患者(56.1±13.5 岁,66.7%为男性)中,39 例诊断为重症,15 例诊断为危重症。危重症患者糖尿病、D-二聚体水平、炎症和心脏标志物的发生率明显升高。肌钙蛋白 I(TnI)升高发生于所有重症和危重症患者的 42.6%。入院时 3 例患者发生低血压,均诊断为危重症。住院期间 1 例重症和 7 例危重症患者出现低血压。窦性心动过速是最常见的心律失常类型,见于 23 例重症患者和所有危重症患者。终末期危重症患者可见房室传导阻滞和室性心动过速,缓慢性心律失常和心房颤动少见。1 例重症和 5 例危重症患者可见轻度心包积液。3 例危重症患者新发心力衰竭。治疗期间低血压、严重心肌损伤和心包积液是预测 COVID-19 感染危重症状态的独立危险因素。
本研究系统观察了 COVID-19 对重症和危重症患者心血管系统的影响,包括心肌损伤、血压、心律失常和心功能。监测 COVID-19 患者的生命体征和心功能,尤其是对治疗期间低血压、严重心肌损伤或心包积液的患者,应用潜在干预措施非常重要。